Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
770.00 | -48,73% | -27,69% | 693.312,15 | 0,67% | 2,63% |
|
NasdaqGS:AVGO
Broadcom
|
1395.29 | -44,29% | -32,72% | 646.607,02 | 1,49% | 15,2% |
|
CPSE:NOVO B
Novo Nordisk A/S
|
903.30 | -1,06% | 19,47% | 4.007.181,69 | 1,03% | 18,5% |
|
NYSE:JNJ
Johnson & Johnson
|
154.64 | 0% | 0% | 372.168,87 | 3,21% | 2,71% |
|
NYSE:MRK
Merck
|
131.19 | -10,02% | 3,18% | 332.278,86 | 2,35% | -19,03% |
|
NYSE:ABBV
AbbVie
|
166.42 | -23,06% | -12,89% | 293.875,72 | 3,77% | 7,03% |
|
LSE:AZN
AstraZeneca PLC
|
121.10 | 18,89% | 41,61% | 187.733,46 | 2,01% | 15,98% |
|
SWX:NOVN
Novartis
|
93.37 | 8,15% | 21,52% | 190.512,74 | 3,56% | 4,67% |
|
NYSE:DHR
Danaher
|
265.80 | -20,56% | -10,01% | 196.874,48 | 0,4% | 10,89% |
|
NYSE:ABT
Abbott Laboratories
|
104.09 | 2,43% | 15,17% | 181.078,48 | 2,1% | 9,04% |
|
NYSE:GE
General Electric
|
159.89 | 1,9% | 33,49% | 175.016,66 | 0,7% | -11,58% |
|
NasdaqGS:AMGN
Amgen
|
312.47 | -12,26% | -3,47% | 167.619,75 | 2,86% | 5,31% |
|
NYSE:MDT
Medtronic
|
85.92 | 24,15% | 37% | 114.086,51 | 3,22% | 2,09% |
|
ENXTPA:AI
L'Air Liquide
|
185.64 | -0,03% | 11,13% | 97.053,18 | 1,73% | 8,09% |
|
LSE:GSK
GSK
|
17.75 | 7,44% | 23,26% | 72.385,16 | 3,25% | 0,79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.03 | 61,74% | 72,08% | 89.253,22 | 5,44% | 13,54% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.72 | 20,9% | 30,15% | 84.363,86 | 4,54% | 0,15% |
|
NYSE:PH
Parker-Hannifin Corp
|
545.11 | -32,37% | -25,2% | 70.068,98 | 1,21% | 15,64% |
|
NYSE:BDX
Becton Dickinson and Co
|
236.30 | 15,46% | 29,59% | 68.292,23 | 1,61% | 2,09% |
|
TSE:4568
Daiichi Sankyo Company
|
5531.00 | 0% | 0% | 10.602.623,29 | 1,09% | 0% |
